ADHD medication treatment and risk of psychosis.
暂无分享,去创建一个
[1] P. Lichtenstein,et al. Methylphenidate and the risk of psychosis in adolescents and young adults: a population-based cohort study , 2019, The lancet. Psychiatry.
[2] S. Schneeweiss,et al. Psychosis with Methylphenidate or Amphetamine in Patients with ADHD , 2019, The New England journal of medicine.
[3] Elizabeth B. Owens,et al. Young adult outcomes in the follow‐up of the multimodal treatment study of attention‐deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression , 2017, Journal of child psychology and psychiatry, and allied disciplines.
[4] Elizabeth B. Owens,et al. Functional Adult Outcomes 16 Years After Childhood Diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA Results. , 2016, Journal of the American Academy of Child and Adolescent Psychiatry.
[5] Liang-Jen Wang,et al. Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: A nationwide population-based study in Taiwan , 2015, Schizophrenia Research.
[6] L. Hechtman,et al. Reintroduction of stimulant treatment for patients with ADHD, after stimulant-related psychosis , 2014 .
[7] L. Hechtman,et al. Psychosis in a boy with ADHD treated with stimulants and acute lymphocytic leukemia treated with chemotherapy and steroids , 2013 .
[8] J. Biederman,et al. Risperidone treatment for ADHD in children and adolescents with bipolar disorder , 2008, Neuropsychiatric disease and treatment.